Description

D-JBD19 is a non-permeable peptide[1]. D-JBD19 has neuroprotective effects[2].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)–Neuroscience-Neuromodulation–C99H164N32O28—-[1]Cardozo AK, et al. Cell-permeable peptides induce dose- and length-dependent cytotoxic effects. Biochim Biophys Acta. 2007 Sep;1768(9):2222-34.|[2]Vaslin A, et al. Excitotoxicity-induced endocytosis mediates neuroprotection by TAT-peptide-linked JNK inhibitor. J Neurochem. 2011 Dec;119(6):1243-52.–954134-42-0–2250.56–99.84–N=C(N)NCCC[C@H](C(O)=O)NC([C@@H]1N(C([C@@H](CCCCN)NC([C@@H](CCCNC(N)=N)NC([C@@H]2N(C([C@@H]([C@@H](O)C)NC([C@@H]([C@@H](O)C)NC([C@@H](CC(C)C)NC([C@@H](CC(N)=O)NC([C@@H](CC(C)C)NC([C@@H](CC3=CC=CC=C3)NC([C@@H]4N(C([C@@H](CCC(N)=O)NC([C@@H](C(C)C)NC([C@@H]5N(C([C@@H](CCCNC(N)=N)NC([C@@H](CO)NC([C@@H](CCC(N)=O)NC([C@@H](CC(O)=O)N)=O)=O)=O)=O)CCC5)=O)=O)=O)CCC4)=O)=O)=O)=O)=O)=O)=O)CCC2)=O)=O)=O)CCC1)=O–Neurological Disease–10 mM in DMSO–Others—-Others–Peptides